Press Releases

Download the PDF of this press release here.

FOR IMMEDIATE RELEASE

Santa Clara, CA, October 17, 2024, Minerva Surgical, a manufacturer and distributor of minimally invasive gynecologic technologies, today announced a new strategic partnership with Blackmaple Group, designed to provide access to office-based solutions for its Women’s Health Administrative and Purchasing Alliance (WHAAPA) physician members for the detection and treatment of uterine conditions.

The Medical Endoscopy Image Processing System and the Minerva ES Ablation System – both of which will be available to BMG WHAAPA members under this new agreement – are designed to quickly and effectively address causes of Abnormal Uterine Bleeding (AUB) a set of debilitating conditions affecting one in three women. Left untreated, AUB may drive women to withdraw or become absent from family, social, and work activities. Some of these conditions can be life threatening, if not detected early.

According to Darin Hammers, CEO of Minerva Surgical, “Integrating hysteroscopy into the office setting enables gynecologists to detect uterine cavity disease earlier and more accurately than using other, less sensitive methods. The Minerva ES endometrial ablation can be performed in the comfort of the office setting, while reducing the cost to the patient. Effectiveness of the Minerva ES has been proven in clinical trials demonstrating procedure safety and long-term avoidance of hysterectomy in over 99% of the patients.”

Additionally, Minerva ES is a one-time, non-hormonal, incisionless treatment with the recovery time of 1-2 days. “The agreement with Minerva Surgical is important to Blackmaple Group because it provides WHAAPA members with more options to safely and effectively treat patients in the office setting”, said Dr. Jeff Gold, CEO of BMG.

About Minerva Surgical: Minerva Surgical is a Women’s Health company committed to improving women’s health and quality of life by providing access to minimally invasive, technologically advanced, and innovative solutions for early detection, treatment, and management of uterine conditions.

For more information about the innovative medical devices of Minerva Surgical, please visit: www.MinervaSurgical.com.

About Blackmaple Group: founded in 2008 as a consulting firm focused on bringing business rigor to provider group management, the Blackmaple Group (BMG) has grown to become an industry leader in procurement, medical group management and healthcare economics. Under the leadership of its founder Dr. Jeff Gold and COO Marc Cooper, BMG has grown to over 16,000 physician members across the United States and continues to add new clients every day.

Contact:

Minerva Surgical
4255 Burton Drive
Santa Clara, CA 95054
Media/Press: kevin.tracey@minervasurgical.com

Download the PDF of this press release here.

FOR IMMEDIATE RELEASE

Santa Clara, CA, October 16, 2024, As the nationwide saline shortage impacts healthcare facilities across the country and the number of elective procedures is being reduced or halted, The Symphion technology from Minerva Surgical offers a solution to help gynecologists mitigate the rationing of saline for operative hysteroscopy procedures.

A key feature of the Symphion Operative Hysteroscopy System is the fluid recirculation system. Unlike many uterine tissue removal products that use multiple bags of saline for operative hysteroscopy procedures, Symphion is designed to use one bag of saline during the uterine polyp or uterine fibroid removal. Symphion is the only operative hysteroscopy system with the capability to filter and recirculate saline for continuous use during each procedure.

In addition to conserving saline with the fluid recirculation feature, Symphion may improve procedural efficiency by eliminating a workflow disruption or stoppage to replace a depleted bag of saline. This is a common occurrence with open-loop, weight-based fluid management systems. Other features of the Symphion Operative Hysteroscopy System include:

• Volumetrically limit patient exposure to saline fluid absorption below the
  maximum AAGL guidelines of 2500mL
• One bipolar RF tissue resecting device to remove uterine polyps and fibroids
• Control persistent bleeding with optional coagulation function, which ACOG
  recognized as an advantage for a tissue removal device
• Maintain visibility with independent on-demand aspiration to flush the uterine
  cavity
• Optional digital fluid deficit readout device

Darin Hammers, Minerva Surgical Chief Executive Officer said, “Symphion was engineered to address the needs of operative hysteroscopy. We are proud to support our physician and health system partners with a solution to help navigate this critical saline supply shortage and help them continue to provide relief to patients that suffer from Abnormal Uterine Bleeding (AUB).”

About Minerva Surgical: Minerva Surgical is a Women’s Health company committed
to improving women’s health and quality of life by providing access to minimally
invasive, technologically advanced, and innovative solutions for early detection,
treatment, and management of uterine conditions.

For more information about the innovative medical devices of Minerva Surgical, please visit: www.MinervaSurgical.com.

Contact:

Minerva Surgical
4255 Burton Drive
Santa Clara, CA 95054
Media/Press: kevin.tracey@minervasurgical.com

Download the PDF of this press release here.

Santa Clara, California, August 26, 2024, Minerva Surgical, a manufacturer and distributor of minimally invasive gynecologic surgical technologies, today announced the launch of the Symphion Fluid Deficit Readout, an optional accessory that provides fluid deficit volume readings during operative hysteroscopy procedures.

Operative hysteroscopy is a surgical procedure that requires precise fluid management to prevent complications. The Symphion Fluid Deficit Readout, which is intended for use with the Symphion Operative Hysteroscopy System, automatically calculates the fluid deficit during the procedure by measuring the weight of the saline bag throughout the procedure in real time and converting the weight measurement into fluid volume readings.

Additional key features of the Symphion Fluid Deficit Readout includes a fluid deficit accuracy within +/- 50mL, a user-friendly interface with an intuitive display for easy operation, and a compact design that allows for quick set up with the Symphion controller.

“Continuous innovation with a focus on enhancing patient safety has always been the primary objective for Minerva Surgical. The Symphion Operative Hysteroscopy System is intended to volumetrically limit a patient’s exposure to fluid so the risk of fluid absorption and overload can be avoided. With the introduction of the Symphion Fluid Deficit Readout, the system has a new layer of procedural safety to complement the unprecedented precision during uterine cavity tissue resection.”, states Minerva Surgical Chief Medical Officer Eugene Skalnyi, M.D.

The Symphion Fluid Deficit Readout is the latest product launch to the Minerva Surgical portfolio of minimally invasive technologies. The company is committed to advancing gynecologic surgery and providing solutions that enhance outcomes.

About Minerva Surgical, Inc. Minerva Surgical is a commercial-stage medical technology company focused on developing, manufacturing, distributing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The Company has established a broad product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. The Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies.

For more information about the innovative medical devices of Minerva Surgical, please visit: www.MinervaSurgical.com.

Contact:

Minerva Surgical
4255 Burton Drive
Santa Clara, CA 95054
Media/Press: kevin.tracey@minervasurgical.com

Download the PDF of this press release here.

Santa Clara, CA, August 19, 2024 – Today, Minerva Surgical announced the appointment of Darin Hammers as the new President and Chief Executive Officer and Member of the Board.

With a 30-year proven track record of success and excellence, Mr. Hammers brings a wealth of expertise and leadership to the company as it continues to develop and commercialize minimally invasive gynecologic technologies that improve patient outcomes.

Most recently, Mr. Hammers served as President and Chief Executive Officer of EndoGastric Solutions (EGS), which was recently acquired by Merit Medical. Prior to EGS, he served as Chief Executive Officer of DYSIS Medical and President and Chief Executive Officer of Cogentix Medical, a company that was acquired by Laborie in 2018. Mr. Hammers was formerly Vice President of Sales for the Bard Medical Division of C.R. Bard, and he spent over twelve years in leadership positions with the Urology and Gynecology division at Boston Scientific Corporation.

During his tenure in the medical device industry, Mr. Hammers consistently demonstrated the ability to build high-performing organizations and teams that deliver exceptional results. Minerva Surgical Chairman Dr. Uri Geiger said: “We are delighted to welcome Darin as our new President and Chief Executive Officer. Mr. Hammers is a dynamic business leader with exceptional strategic capabilities, proven operational effectiveness and strong experience in women’s health. The Board looks forward to working with Darin as we grow Minerva’s platform of exceptional products for women’s care.”

Mr. Hammers stated: “I am delighted to join Minerva Surgical and build a company that will develop new and innovative technologies to improve the quality of life for women. The core portfolio of products is as effective as any on the market when it comes to treating uterine cavity conditions, and the goal is to expand our footprint in the gynecology space and become a market leader.”

Darin Hammers holds an MBA from Emory University’s Goizueta School of Business and a Bachelor of Science degree in marketing from the University of Southern Indiana.

About Minerva Surgical, Inc. Minerva Surgical is a commercial-stage medical technology company focused on developing, manufacturing, distributing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The Company has established a broad product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. The Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies.

For more information about the innovative medical devices of Minerva Surgical, please visit: www.MinervaSurgical.com.

Contact:

Minerva Surgical
Santa Clara, CA 95054
Media Contact: Kevin A. Tracey
Media/Press: kevin.tracey@minervasurgical.com

Download the PDF of this press release here.

Santa Clara, CA, Thursday May 16, 2024 – Minerva Surgical announces the immediate and exclusive distribution of a new disposable hysteroscope that will be displayed at the Annual Clinical & Scientific Meeting of American College of Obstetricians and Gynecologists in San Francisco, CA. The company plans to soon rebrand the new disposable hysteroscope as HERizon, and their goal is to redefine the standards of efficiency and accessibility in gynecological care.

“This marks a significant milestone in the company’s mission to address the needs of gynecologists and further advance Women’s Health,” states Minerva Surgical Chief Medical Officer Eugene Skalnyi, M.D. “HERizon embodies versatility as a hysteroscope, facilitating an array of procedures both in the operating room and office settings. It is one of a few technologies that our team plans to launch to better serve the evolving patterns in Gynecology.”

The HERizon Disposable Hysteroscope is a cutting-edge system that is introduced in alignment with ACOG and AAGL’s advocacy for the elimination of blind assessment practices in the uterine cavity. Several key features of the HERizon Disposable Hysteroscope include:

• Disposable Design: Single-use hysteroscope eliminates the need for traditional hysteroscope reprocessing, reduces the risk of cross-contamination, and ensures compliance with sterility standards.
• Angled Cannula Tip: Provides rigidity to help enter the cervical canal and articulation to navigate an array of uterine cavity positions.
• Compact Footprint: 4.8mm outer diameter sheath requires minimal or no dilation and 6Fr  working channel allows for a broad spectrum of procedures such as direct visualization polypectomy, endometrial biopsy, D&C, and IUD removal.
• User-Friendly Interface: High-Definition image technology, two LED lights provide bright and clear visualization, and the intuitive interface enables seamless system navigation.

Dr. David Glassman, DO FACOG EMIGS, a prominent gynecologist in Phoenix, Arizona, shared his excitement about the new HERizon Disposable Hysteroscope, stating, “HERizon is a revolutionary advancement in hysteroscopy technology. Designed with precision and patient comfort in mind, HERizon offers unparalleled clarity and control, providing healthcare professionals with a clearer view and easier access to the uterine cavity. Its innovative features enhance procedural efficiency, reducing both patient discomfort and procedure times. With HERizon, healthcare providers can elevate their practice, delivering superior care and empowering women to take control of their health with confidence.”

The introduction of the HERizon Disposable Hysteroscope underscores Minerva Surgical’s commitment to providing gynecologists with solutions that improve patient outcomes.

About Minerva Surgical, Inc. Minerva Surgical is a commercial-stage medical technologycompany focused on developing, manufacturing, distributing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The Company has >established a broad product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. The Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies.

For more information about the HERizon Disposable Hysteroscope and other innovative medical devices from Minerva Surgical, please visit www.MinervaSurgical.com. The disposable hysteroscope is manufactured by Jiyuan Medical.

Contact:

Minerva Surgical
4255 Burton Drive
Santa Clara, CA 95054
Media Contact: Kevin A. Tracey
Media/Press: media@minervasurgical.com